Literature DB >> 11123060

Familial autoimmunity and the idiopathic inflammatory myopathies.

E A Shamim1, F W Miller.   

Abstract

Many lines of evidence suggest that autoimmune diseases result from chronic immune activation following environmental exposures in genetically susceptible individuals. A genetic basis for autoimmunity is supported by twin and family studies, candidate gene investigations, animal models, and whole genome microsatellite scans. These findings predict, and clinical observations support, familial clustering of a number of individual autoimmune diseases, notably lupus, multiple sclerosis, type-1 diabetes mellitus, rheumatoid arthritis, and recently the idiopathic inflammatory myopathies. Yet, not only is the same autoimmune disease increased in prevalence in pedigrees of persons affected with a given disorder, but other autoimmune diseases are as well. We review these data and propose a hypothesis consistent with these findings. This model posits that a rheumatic disease, as currently classified, is actually composed of a number of elemental disorders. Each of these is defined by the minimal necessary and sufficient environmental exposures and genes that result in a pathology leading to a given sign-symptom complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123060     DOI: 10.1007/s11926-000-0080-0

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  101 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Dermatomyositis; unusual features, complications, and treatment.

Authors:  L A BRUNSTING; H B CHRISTIANSON; H O PERRY
Journal:  AMA Arch Derm       Date:  1956-12

Review 3.  Overview: infectious agents as etiologic triggers of autoimmune disease.

Authors:  M B Oldstone
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

Review 4.  Microsatellites in the HLA region: 1998 update.

Authors:  A Foissac; A Cambon-Thomsen
Journal:  Tissue Antigens       Date:  1998-10

Review 5.  Panning for gold: genome-wide scanning for linkage in type 1 diabetes.

Authors:  J A Todd; M Farrall
Journal:  Hum Mol Genet       Date:  1996       Impact factor: 6.150

Review 6.  Genetic susceptibility to the development of autoimmune disease.

Authors:  J Heward; S C Gough
Journal:  Clin Sci (Lond)       Date:  1997-12       Impact factor: 6.124

7.  The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus.

Authors:  D Thompson; A Juby; P Davis
Journal:  Lupus       Date:  1993-02       Impact factor: 2.911

8.  Unusual clustering of diseases in a Canadian Old Colony (Chortitza) Mennonite kindred and community.

Authors:  M A Jaworski; J D Slater; A Severini; K R Hennig; G Mansour; J G Mehta; R Jeske; J Schlaut; C Y Pak; J W Yoon
Journal:  CMAJ       Date:  1988-06-01       Impact factor: 8.262

9.  Family study of systemic lupus erythematosus: analysis of the clinical history, skin immunofluorescence, and serologic parameters.

Authors:  M B Lowenstein; N F Rothfield
Journal:  Arthritis Rheum       Date:  1977 Sep-Oct

10.  Does the history of multiple sclerosis go back as far as the 14th century?

Authors:  R Medaer
Journal:  Acta Neurol Scand       Date:  1979-09       Impact factor: 3.209

View more
  3 in total

1.  Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up.

Authors:  K P Ng; F Ramos; S M Sultan; D A Isenberg
Journal:  Clin Rheumatol       Date:  2009-04-23       Impact factor: 2.980

2.  Autoimmune joint diseases in Late Medieval skeletal sample from Croatia.

Authors:  Petra Rajić Sikanjić; Dejana Vlak
Journal:  Rheumatol Int       Date:  2009-05-20       Impact factor: 2.631

Review 3.  Evaluation and management of bradycardia in neonates and children.

Authors:  Alban-Elouen Baruteau; James C Perry; Shubhayan Sanatani; Minoru Horie; Anne M Dubin
Journal:  Eur J Pediatr       Date:  2016-01-16       Impact factor: 3.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.